MTOR and Alzheimer disease: These catalytic mTOR inhibitors have been shown to rescue or correct hyperactivated mTOR signaling by induction of autophagy, and have demonstrated effectiveness at blocking the phosphorylation of 4E-BP1, showing reduced hallmarks of AD, and recovered cognitive performances [159,160,161,162].